Updated:
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001042074, and its reported...
Overview
CymaBay Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001042074, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2024-02-28, it reported annual revenue of USD 31,073,000; net income of USD -105,370,000; total assets of USD 434,686,000 for the fiscal period ended 2023-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- CymaBay Therapeutics, Inc.
- Former names in filing history
- METABOLEX, INC. (2009-07-21 to 2009-11-10); METABOLEX INC (2002-02-19 to 2009-03-05)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Newark, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001042074
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2023USD | $31.1M | -$105.4M | $434.7M | $206.5M | -$72.5M | |
| FY2022USD | — | -$106.0M | $141.9M | $20.3M | -$84.1M | |
| FY2021USD | — | -$90.0M | $202.3M | $125.8M | -$69.4M | |
| FY2020USD | — | -$51.0M | $153.8M | $28.2M | -$44.7M |
FY2021. Operating cash flow: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-K | 10-K | ||
| SC 13G | — | JHG PLC OWNS >5% | |
| SC 13G | — | SCHEDULE 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| SC 13G | — | Form SC 13G | |
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13G | — | SC 13G |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research CymaBay Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.